Ascend Wellness Holdings Files 8-K

Ticker: AAWH · Form: 8-K · Filed: Dec 27, 2024 · CIK: 1756390

Ascend Wellness Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyAscend Wellness Holdings, Inc. (AAWH)
Form Type8-K
Filed DateDec 27, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$2.25 million
Sentimentneutral

Sentiment: neutral

Topics: 8-K, SEC Filing, Other Events

Related Tickers: AAWH

TL;DR

AWH filed an 8-K on 12/27. Details TBD.

AI Summary

Ascend Wellness Holdings, Inc. filed an 8-K on December 27, 2024, reporting an event under 'Other Events'. The filing does not contain specific details about the event itself, only the standard reporting information for a current report.

Why It Matters

This filing indicates a material event has occurred that Ascend Wellness Holdings, Inc. is required to report to the SEC, though the specific nature of the event is not detailed in this summary.

Risk Assessment

Risk Level: low — The filing is a standard 8-K notification and does not contain specific financial or operational details that would immediately indicate risk.

Key Numbers

  • 20241227 — Filing Date (The date the 8-K was filed with the SEC.)

Key Players & Entities

  • Ascend Wellness Holdings, Inc. (company) — Registrant
  • 0001756390 (company) — Central Index Key
  • 20241227 (date) — Filing Date

FAQ

What specific event is Ascend Wellness Holdings, Inc. reporting under 'Other Events'?

The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.

When was this 8-K filed?

The 8-K was filed on December 27, 2024.

What is the exact name of the registrant?

The exact name of the registrant is Ascend Wellness Holdings, Inc.

In which state is Ascend Wellness Holdings, Inc. incorporated?

Ascend Wellness Holdings, Inc. is incorporated in Delaware.

What is the principal executive office address for Ascend Wellness Holdings, Inc.?

The principal executive office is located at 44 Whippany Road, Suite 101, Morristown, NJ 07960.

Filing Stats: 575 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-12-27 17:16:35

Key Financial Figures

  • $2.25 million — s outstanding Common Shares; and (ii) US$2.25 million worth of Common Shares, in the open mar

Filing Documents

01. Other Events

Item 8.01. Other Events. On December 27, 2024, Ascend Wellness Holdings, Inc. (the "Company") announced that it has received authorization from the Company's Board of Directors to commence a share buyback program ("Buyback Program"). Pursuant to a normal course issuer bid ("NCIB") commencing on January 2, 2025, the Company may repurchase up to the lesser of: (i) 10,215,690 shares of the Company's class A common stock ("Common Shares"), representing approximately 5.0% of the Company's outstanding Common Shares; and (ii) US$2.25 million worth of Common Shares, in the open market. As of December 24, 2024, there were a total of 204,313,808 issued and outstanding Common Shares. Common Shares may be purchased on the Canadian Securities Exchange ("CSE"), the OTCQX, or alternative trading systems, subject to applicable legal, regulatory and contractual requirements. All purchases made will be through the selected purchasing member, ATB Securities Inc. The total number of Common Shares purchased, timing of purchases, and share price are dependent upon market conditions and business considerations, any applicable securities law requirements, CSE rules and any determination of best use of cash available at the time. Any Common Shares purchased will be cancelled. The Buyback Program will expire on January 1, 2026, and may be suspended, terminated or modified at any time for any reason. While the Company intends to proceed with the Buyback Program, it is under no obligation to purchase any Common Shares for the duration of the Buyback Program. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ascend Wellness Holdings, Inc. December 27, 2024 /s/ Roman Nemchenko Roman Nemchenko Chief Financial Officer (Principal Financial Officer) 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.